This article explores the powerful synergy between CRISPR-Cas9 gene editing and induced pluripotent stem cell (iPSC) technology, a combination that is revolutionizing disease modeling and therapeutic development.
Kidney organoids derived from human induced pluripotent stem cells (iPSCs) have emerged as a transformative platform for modeling renal development and disease.
This article provides a comprehensive analysis of the process to differentiate human induced pluripotent stem cells (iPSCs) into functional, insulin-producing beta cells.
This article provides a comprehensive overview of induced pluripotent stem cell (iPSC) models and their transformative role in Parkinson's disease (PD) research.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are revolutionizing cardiovascular research by providing a patient-specific, human-relevant platform for disease modeling and drug development.
Human induced pluripotent stem cells (iPSCs) have revolutionized the study of Alzheimer's disease (AD), enabling researchers to model amyloid-beta (Aβ) deposition in a patient-specific context.
This article provides a comprehensive overview of how human induced pluripotent stem cells (iPSCs) are revolutionizing the study of neurodevelopmental disorders (NDDs).
Patient-specific induced pluripotent stem cells (iPSCs) are revolutionizing the study and treatment of neurodegenerative diseases.
Human induced pluripotent stem cells (hiPSCs) have emerged as a transformative platform for investigating the mechanistic roles of Apolipoprotein E (APOE) isoforms in Alzheimer's Disease (AD) and other neurodegenerative conditions.
This article provides a comprehensive resource for researchers and drug development professionals on utilizing induced pluripotent stem cells (iPSCs) to model rare genetic diseases.